Why the study?
Are elevated Nt-proBNP levels associated with increased risk of early cardiovascular events in patients with NSTEMI?
Are elevated Nt-proBNP levels associated with increased risk of early cardiovascular events in patients with NSTEMI?
Answers are grounded in this paper and cite their sources.
Elevated Nt-proBNP levels in NSTEMI patients are associated with an increased risk of early in-hospital cardiovascular events.
METHODS AND RESULTS: 101 patients hospitalized for acute non-ST-elevation myocardial infarction (NSTEMI) were included in the study. Median N-terminal fragment of the brain natriuretic peptide (BNP) prohormone (Nt-proBNP) plasma level was 136 (40-335) pmol/l. Patients with increasing levels of troponin I [from low (0.1-10 ng/ml), intermediate (10-40 ng/ml) to high (> or =40 ng/ml) levels] had significantly increased levels of Nt-proBNP (p < 0.05). High-risk patients classified by a high PURSUIT score (i.e. supramedian) had significantly increased Nt-proBNP levels compared to patients with low scores (p < 0.001). Moreover, patients with in-hospital events (death, recurrent MI or clinical heart failure: 27%) had significantly increased median levels of Nt-proBNP compared to event-free patients (184 vs. 105 pmol/l, p = 0.02). CONCLUSION: Our data in an unselected population of NSTEMI patients indicate that high levels of circulating Nt-proBNP levels are associated with an increased risk of early cardiovascular events.
No takes yet. Share an insight, caveat, or question.
Zeller et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: